Author response to: Resection margin status in pancreatic cancer surgery: is it really less important than the N status?

J V Groen¹, W S Tummers¹, J S Mieog¹, R J Swijnenburg^{1

2}

Affiliations

¹ Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.

Comment

J V Groen et al. Br J Surg. 2019 Oct.

. 2019 Oct;106(11):1559-1560.

doi: 10.1002/bjs.11355.

J V Groen¹, W S Tummers¹, J S Mieog¹, R J Swijnenburg^{1

2}

¹ Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.

No abstract available

Comment on

Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, Morreau J, Putter H, van de Velde CJ, Vahrmeijer AL, Bonsing BA, Mieog JS, Swijnenburg RJ. Tummers WS, et al. Br J Surg. 2019 Jul;106(8):1055-1065. doi: 10.1002/bjs.11115. Epub 2019 Mar 18. Br J Surg. 2019. PMID: 30883699 Free PMC article.
Resection margin status in pancreatic cancer surgery: is it really less important than the N status?
Fiorillo C, Quero G, Alfieri S. Fiorillo C, et al. Br J Surg. 2019 Oct;106(11):1559. doi: 10.1002/bjs.11356. Br J Surg. 2019. PMID: 31577052 No abstract available.

1. Tummers WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, Morreau J, Putter H et al. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 2019; 106: 1055-1065.
1. van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, de Pastena M et al. International validation of the Eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg 2018; 153: e183617.
1. Baugh KA, Tran Cao HS, van Buren G 2nd, Silberfein EJ, Hsu C, Chai C et al. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery 2019; 165: 307-314.
1. Tummers WS, Miller SE, Teraphongphom NT, van den Berg NS, Hasan A, Longacre TA et al. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. HPB (Oxford) 2019; 21: 883-890.
1. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210.